Etoricoxib - preemptive and postoperative analgesia (EPPA) in patients with laparotomy or thoracotomy - design and protocols

Trials

Volumn 11, Issue , 2010, Pages

  Fleckenstein, Johannes ^a   Kramer, Sybille ^a   Offenbächer, Martin ^a   Schober, Gabriel ^a   Plischke, Herbert ^a   Siebeck, Matthias ^a   Mussack, Thomas ^a   Hatz, Rudolf ^b   Lehmeyer, Lukas ^a,c   Lang, Philip M ^a   Heindl, Bernhard ^a   Conzen, Peter ^a   Irnich, Dominik ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HAWKE S BAY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ETORICOXIB; MORPHINE; MULTIDRUG RESISTANCE PROTEIN 1; PLACEBO; ANALGESIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYP2C19 PROTEIN, HUMAN; NARCOTIC AGENT; PYRIDINE DERIVATIVE; SULFONE; UNSPECIFIC MONOOXYGENASE;

ABDOMINAL SURGERY; ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GENETIC POLYMORPHISM; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREEMPTIVE ANALGESIA; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THORACOTOMY; THORAX SURGERY; DRUG ADMINISTRATION; DRUG EFFECT; GENETICS; GERMANY; HYPERALGESIA; METABOLISM; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PLACEBO EFFECT; TIME; TREATMENT OUTCOME;

ANALGESIA; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; ARYL HYDROCARBON HYDROXYLASES; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; GERMANY; HUMANS; HYPERALGESIA; LAPAROTOMY; MORPHINE; NARCOTICS; PAIN MEASUREMENT; PAIN THRESHOLD; PAIN, POSTOPERATIVE; PLACEBO EFFECT; POLYMORPHISM, GENETIC; PYRIDINES; RESEARCH DESIGN; SULFONES; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954036644     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-66     Document Type: Article

References (57)

1. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006, 367:1618-1625. 10.1016/S0140-6736(06)68700-X, 16698416.
2. Bonnet F, Marret E. Postoperative pain management and outcome after surgery. Best Pract Res Clin Anaesthesiol 2007, 21:99-107. 10.1016/j.bpa.2006.12.007, 17489222.
3. Dolin SJ, Cashman JN, Bland JM. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth 2002, 89:409-423. 10.1093/bja/aef207, 12402719.
4. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002, 183:630-641. 10.1016/S0002-9610(02)00866-8, 12095591.
5. White PF, Kehlet H, Neal JM, Schricker T, Carr DB, Carli F. The role of the anesthesiologist in fast-track surgery: from multimodal analgesia to perioperative medical care. Anesth Analg 2007, 104:1380-1396. table of contents, 10.1213/01.ane.0000263034.96885.e1, 17513630.
6. White PF, Kehlet H. Improving postoperative pain management: what are the unresolved issues?. Anesthesiology 2010, 112:220-225. 10.1097/ALN.0b013e3181c6316e, 20010418.
7. Grape S, Tramer MR. Do we need preemptive analgesia for the treatment of postoperative pain?. Best Pract Res Clin Anaesthesiol 2007, 21:51-63. 10.1016/j.bpa.2006.11.004, 17489219.
8. Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain 2008, 9:122-145. 10.1016/j.jpain.2007.09.006, 2278005, 18088561.
9. Brennan TJ, Kehlet H. Preventive analgesia to reduce wound hyperalgesia and persistent postsurgical pain: not an easy path. Anesthesiology 2005, 103:681-683. 10.1097/00000542-200510000-00004, 16192759.
10. Crile GW. The kinetic theory of shock and its prevention through anoci-association (shockless operation). Lancet 1913, ii:7-16.
11. Melzack R, Coderre TJ, Katz J, Vaccarino AL. Central neuroplasticity and pathological pain. Ann N Y Acad Sci 2001, 933:157-174.
12. Ong CK, Lirk P, Seymour RA, Jenkins BJ. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg 2005, 100:757-773. table of contents, 10.1213/01.ANE.0000144428.98767.0E, 15728066.
13. Moiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology 2002, 96:725-741. 10.1097/00000542-200203000-00032, 11873051.
14. Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand 2000, 44:1191-1203. 10.1034/j.1399-6576.2000.441003.x, 11065198.
15. Souter AJ, Fredman B, White PF. Controversies in the perioperative use of nonsterodial antiinflammatory drugs. Anesth Analg 1994, 79:1178-1190. 10.1213/00000539-199412000-00025, 7978444.
16. Sinatra R. Role of COX-2 inhibitors in the evolution of acute pain management. J Pain Symptom Manage 2002, 24:S18-27. 10.1016/S0885-3924(02)00410-4, 12204484.
17. Barton SF, Langeland FF, Snabes MC, LeComte D, Kuss ME, Dhadda SS, Hubbard RC. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology 2002, 97:306-314. 10.1097/00000542-200208000-00004, 12151917.
18. Buvanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, Rosenberg AG. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. Jama 2003, 290:2411-2418. 10.1001/jama.290.18.2411, 14612477.
19. Sinatra RS, Shen QJ, Halaszynski T, Luther MA, Shaheen Y. Preoperative rofecoxib oral suspension as an analgesic adjunct after lower abdominal surgery: the effects on effort-dependent pain and pulmonary function. Anesth Analg 2004, 98:135-140. table of contents, 10.1213/01.ANE.0000085637.00864.D7, 14693607.
20. Takemoto JK, Reynolds JK, Remsberg CM, Vega-Villa KR, Davies NM. Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib. Clin Pharmacokinet 2008, 47:703-720. 10.2165/00003088-200847110-00002, 18840026.
21. Karamanlioglu B, Alagol A, Turan FN. Preemptive oral rofecoxib plus postoperative intraarticular bupivacaine for pain relief after arthroscopic knee surgery. Agri 2005, 17:29-33.
22. Horattas MC, Evans S, Sloan-Stakleff KD, Lee C, Snoke JW. Does preoperative rofecoxib (Vioxx) decrease postoperative pain with laparoscopic cholecystectomy?. Am J Surg 2004, 188:271-276. 10.1016/j.amjsurg.2004.06.007, 15450833.
23. Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002, 94:55-59. table of contents, 10.1097/00000539-200201000-00010, 11772800.
24. Nagel B, Gerbershagen HU, Lindena G, Pfingsten M. [Development and evaluation of the multidimensional German pain questionnaire]. Schmerz 2002, 16:263-270. 10.1007/s00482-002-0162-1, 12192435.
25. Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006, 10:77-88. 10.1016/j.ejpain.2005.02.003, 16291301.
26. Kassahun K, McIntosh IS, Shou M, Walsh DJ, Rodeheffer C, Slaughter DE, Geer LA, Halpin RA, Agrawal N, Rodrigues AD. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. Drug Metab Dispos 2001, 29:813-820.
27. Rodrigues AD. Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?. Drug Metab Dispos 2005, 33:1567-1575. 10.1124/dmd.105.006452, 16118328.
28. Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 2002, 96:913-920. 10.1097/00000542-200204000-00019, 11964599.
29. Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, Heijde D, Erdmann E, Laine L, . MEDAL Steering Committee Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006, 368:1771-1781. 10.1016/S0140-6736(06)69666-9, 17113426, MEDAL Steering Committee.
30. Arcoxia Prescribing Information. , http://www.arcoxia.ae/secure/resources/pi/pi.html
31. Barden J, Edwards JE, McQuay HJ, Moore RA. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol 2003, 3:1. 10.1186/1471-2253-3-1, 169173, 12854974.
32. Turaga K, Wright A, Lee R, Dias WP, Destache C, Christian R, Fitzgibbons RJ. A randomized trial of the peri-operative use of COX-2 inhibitors in Lichtenstein herniorrhaphy. Hernia 2008, 12:515-519. 10.1007/s10029-008-0379-8, 18553122.
33. Fong WP, Yang LC, Wu JI, Chen HS, Tan PH. Does celecoxib have pre-emptive analgesic effect after Caesarean section surgery?. Br J Anaesth 2008, 100:861-862. 10.1093/bja/aen113, 18483117.
34. Chau-in W, Thienthong S, Pulnitiporn A, Tantanatewin W, Prasertcharoensuk W, Sriraj W. Prevention of post operative pain after abdominal hysterectomy by single dose etoricoxib. J Med Assoc Thai 2008, 91:68-73.
35. Lenz H, Raeder J. Comparison of etoricoxib vs. ketorolac in postoperative pain relief. Acta Anaesthesiol Scand 2008, 52:1278-1284.
36. Manyou B, Phupong V. Prospective randomized, double-blinded, placebo-controlled trial of preoperative etoricoxib for pain relief in uterine fractional curettage under paracervical block. Eur J Obstet Gynecol Reprod Biol 2008, 140:90-94. 10.1016/j.ejogrb.2008.02.017, 18396369.
37. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Bmj 2006, 332:1302-1308. 10.1136/bmj.332.7553.1302, 1473048, 16740558.
38. Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K. Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol 2003, 43:573-585.
39. Nygaard OP, Trumpy JH, Mellgren SI. Recovery of sensory function after surgical decompression in carpal tunnel syndrome. Acta Neurol Scand 1996, 94:253-257. 10.1111/j.1600-0404.1996.tb07061.x, 8937536.
40. Coderre TJ, Katz J. Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav Brain Sci 1997, 20:404-419.
41. Koltzenburg M. Neural mechanisms of cutaneous nociceptive pain. Clin J Pain 2000, 16:S131-138.
42. Wilder-Smith OH, Arendt-Nielsen L. Postoperative hyperalgesia: its clinical importance and relevance. Anesthesiology 2006, 104:601-607. 10.1097/00000542-200603000-00028, 16508408.
43. Martinez V, Fletcher D, Bouhassira D, Sessler DI, Chauvin M. The evolution of primary hyperalgesia in orthopedic surgery: quantitative sensory testing and clinical evaluation before and after total knee arthroplasty. Anesth Analg 2007, 105:815-821. 10.1213/01.ane.0000278091.29062.63, 2566636, 17717244.
44. Werner MU, Duun P, Kehlet H. Prediction of postoperative pain by preoperative nociceptive responses to heat stimulation. Anesthesiology 2004, 100:115-119. discussion 115A, 10.1097/00000542-200401000-00020, 14695732.
45. Thomas T, Robinson C, Champion D, McKell M, Pell M. Prediction and assessment of the severity of post-operative pain and of satisfaction with management. Pain 1998, 75:177-185. 10.1016/S0304-3959(97)00218-2, 9583753.
46. Slappendel R, Weber EW, Bugter ML, Dirksen R. The intensity of preoperative pain is directly correlated with the amount of morphine needed for postoperative analgesia. Anesth Analg 1999, 88:146-148. 10.1097/00000539-199901000-00027, 9895082.
47. Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI, Chauvin M. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005, 103:147-155. 10.1097/00000542-200507000-00022, 15983467.
48. Ilkjaer S, Bach LF, Nielsen PA, Wernberg M, Dahl JB. Effect of preoperative oral dextromethorphan on immediate and late postoperative pain and hyperalgesia after total abdominal hysterectomy. Pain 2000, 86:19-24. 10.1016/S0304-3959(99)00305-X, 10779656.
49. Nikolajsen L, Ilkjaer S, Jensen TS. Relationship between mechanical sensitivity and postamputation pain: a prospective study. Eur J Pain 2000, 4:327-334. 10.1053/eujp.2000.0194, 11124004.
50. Yasar U, Eliasson E, Dahl ML, Johansson I, Ingelman-Sundberg M, Sjoqvist F. Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population. Biochem Biophys Res Commun 1999, 254:628-631. 10.1006/bbrc.1998.9992, 9920790.
51. Aithal GP, Day CP, Kesteven PJ, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999, 353:717-719. 10.1016/S0140-6736(98)04474-2, 10073515.
52. Matsumoto AK, Cavanaugh PF. Etoricoxib. Drugs Today (Barc) 2004, 40:395-414. 10.1358/dot.2004.40.5.850488, 15319795.
53. Rutherford RB, Quinn MM, Mathur SR, . (Eds) Handbook of Research in Emotional and Behavioral Disorders. 2004, New York: Guilford Press, (Eds).
54. The Research Methods Knowledge Base. , http://www.socialresearchmethods.net/kb/expfact.htm
55. Byth K, Gebski V. Factorial designs: a graphical aid for choosing study designs accounting for interaction. Clin Trials 2004, 1:315-325. 10.1191/1740774504cn026oa, 16279257.
56. Gonen M. Planning for subgroup analysis: a case study of treatment-marker interaction in metastatic colorectal cancer. Control Clin Trials 2003, 24:355-363. 10.1016/S0197-2456(03)00006-0, 12865031.
57. Hochberg Y, Tamhane AC. Multiple comparison procedures. 1987, New York: Wiley.